🇺🇸 Fluzone High-Dose vaccine, 2018-2019 formulation in United States

Fluzone High-Dose vaccine, 2018-2019 formulation (Fluzone High-Dose vaccine, 2018-2019 formulation) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Fluzone High-Dose vaccine, 2018-2019 formulation in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Fluzone High-Dose vaccine, 2018-2019 formulation approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Fluzone High-Dose vaccine, 2018-2019 formulation in United States?

Sanofi Pasteur, a Sanofi Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.